To access this element change to forms mode OFF

Grant Award View - GA29777

GNT1156511 | The designer cytokine IC7: a novel therapy for the...

Contact Details

NHMRC Research Help Centre

Phone:
1800 500 983

Email Address:

GA ID:
GA29777
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2022
Value (AUD):
$1,081,560.00 (GST inclusive where applicable)

Ad hoc/One-off:
No
Aggregate Grant Award:
No

PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
GNT1156511 | The designer cytokine IC7: a novel therapy for the treatment of type 2 Diabetes
Purpose:
Obesity is a world pandemic in the new millennium. It leads to many diseases including type 2 diabetes (T2D). T2D is degenerative, leading to profound health effects. Current therapies are inadequate and approximately half of those diagnosed and being treated are unable to control their disease. Ongoing work in our laboratories has led to the development of a novel protein IC7 which we will test as novel therapeutic strategy for the treatment of T2D.

GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
2018 Project Grant funding commencing 2019
Selection Process:
Targeted or Restricted Competitive

Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property

Grant Recipient Details

Recipient Name:
Garvan Institute of Medical Research
Recipient ABN:
62 330 391 937

Grant Recipient Location

Suburb:
Darlinghurst
Town/City:
Darlinghurst
Postcode:
2010
State/Territory:
NSW
Country:
AUSTRALIA

Grant Delivery Location

State/Territory:
NSW, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, GERMANY

Contact Details

NHMRC Research Help Centre

Phone:
1800 500 983

Email Address: